Dear Editor
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Thank you for the opportunity to respond to the letter from Drs. Lilenbaum, Narduche, Loureiro and Penna regarding our recent serologic and urinary PCR survey of leptospirosis in healthy cats and in cats with chronic kidney disease. We appreciate their interest in the topic.

As is apparent, we consider many of the same issues important in feline health care and we fully agree with the authors regarding the fact that performing PCR alone has its limitations, as mentioned in the discussion section of our article. Although the additional information regarding the specific serovars would have been of great interest, performing real‐time PCR or cultures of the samples was cost prohibitive and not readily available at the time of the execution of our study.

We thank Drs. Lilenbaum, Narduche, Loureiro and Penna again for their interest in the article and for their valued remarks and hope that this more current information regarding leptospirosis in cats will diffuse rapidly into the veterinary profession to increase the awareness of this disease in the feline species.

Sincerely,
